Insider Transactions in Q4 2021 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2021
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Open market or private sale
|
Direct |
6,778
-2.74%
|
$4,446,368
$656.32 P/Share
|
|
Nov 16
2021
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
7,167
-0.71%
|
$4,665,717
$651.16 P/Share
|
|
Nov 15
2021
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
18,222
-35.09%
|
$11,680,302
$641.5 P/Share
|
|
Nov 15
2021
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+32.5%
|
$6,750,000
$270.43 P/Share
|
|
Nov 15
2021
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
9,412
-13.02%
|
$6,033,092
$641.5 P/Share
|
|
Nov 15
2021
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
16,579
+18.66%
|
$862,108
$52.03 P/Share
|
|
Nov 01
2021
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-5.54%
|
$640,000
$640.0 P/Share
|
|
Nov 01
2021
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.25%
|
$342,000
$342.93 P/Share
|
|
Nov 01
2021
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$64,200
$642.92 P/Share
|
|
Oct 04
2021
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
347
-0.24%
|
-
|
|
Oct 01
2021
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-5.54%
|
$576,000
$576.75 P/Share
|
|
Oct 01
2021
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.25%
|
$342,000
$342.93 P/Share
|
|
Oct 01
2021
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$56,900
$569.44 P/Share
|